Shi, Y., Sun, L., Yang, R., Huang, D., Luo, Y., Su, H., Liu, Q., Zhang, P., Li, X., Meng, X., Yao, Y., Min, L., Wang, Y., Yang, L., Xie, C., Yang, J., Shi, J., Xu, Z., Wu, H., Wang, H. (2025). Phase 3 study of benmelstobart in combination with chemotherapy followed by sequential combination with anlotinib for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer (sq-NSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8514